Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease
- PMID: 30970197
- DOI: 10.1056/NEJMc1813435
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease
Comment in
-
Drug-induced reductions in brain amyloid-β levels may adversely affect cognition and behavior by a disruption of functional connectivity homeostasis.Neurodegener Dis Manag. 2019 Aug;9(4):189-191. doi: 10.2217/nmt-2019-0013. Epub 2019 Jul 24. Neurodegener Dis Manag. 2019. PMID: 31337272 No abstract available.
-
Verubecestat for Prodromal Alzheimer's Disease.N Engl J Med. 2019 Jul 25;381(4):388. doi: 10.1056/NEJMc1906679. N Engl J Med. 2019. PMID: 31340105 Free PMC article. No abstract available.
Comment on
-
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840. N Engl J Med. 2019. PMID: 30970186 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical